Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq
Caring Brands (NASDAQ:CABR) closed an underwritten U.S. public offering of 1,000,000 shares at a public offering price of $4.00 per share for aggregate gross proceeds of approximately $4,000,000, before underwriting discounts and offering expenses.
The shares began trading on the Nasdaq Capital Market on November 13, 2025. The underwriter has a 45-day option to purchase up to an additional 150,000 shares at the public offering price, less discounts and commissions. The company intends to use net proceeds for general working capital, marketing and sales, and repayment of certain debt. Registration on Form S-1 (File No. 333-289767) was declared effective on October 30, 2025. D. Boral Capital LLC acted as sole underwriter.
Caring Brands (NASDAQ:CABR) ha chiuso un'offerta pubblica statunitense sottoscritta di 1,000,000 azioni al prezzo di offerta pubblica di $4.00 per azione, per proventi lordi aggregati di circa $4,000,000, prima degli sconti di sottoscrizione e delle spese dell'offerta.
Le azioni hanno iniziato a negoziarsi sul Nasdaq Capital Market il 13 novembre 2025. Il sottoscrittore ha una opzione di 45 giorni per acquistare fino a ulteriori 150,000 azioni al prezzo di offerta pubblica, al netto di sconti e commissioni. L'azienda intende utilizzare i proventi netti per il capitale circolante generale, marketing e vendite e per il rimborso di alcuni debiti. La registrazione sul Modulo S-1 (Numero di File 333-289767) è stata dichiarata efficace il 30 ottobre 2025. D. Boral Capital LLC ha agito come unico sottoscrittore.
Caring Brands (NASDAQ:CABR) cerró una oferta pública estadounidense suscrita de 1,000,000 acciones a un precio de oferta pública de $4.00 por acción, para ingresos brutos agregados de aproximadamente $4,000,000, antes de descuentos de suscripción y gastos de la oferta.
Las acciones comenzaron a cotizar en el Nasdaq Capital Market el 13 de noviembre de 2025. El underwriter tiene una opción de 45 días para comprar hasta 150,000 acciones adicionales al precio de la oferta pública, menos descuentos y comisiones. La empresa tiene la intención de usar los ingresos netos para capital de trabajo general, marketing y ventas y para el pago de ciertas deudas. El registro en Formulario S-1 (N.º de archivo 333-289767) fue declarado efectivo el 30 de octubre de 2025. D. Boral Capital LLC actuó como único suscriptor.
Caring Brands(NASDAQ:CABR)는 1,000,000주를 공모가 $4.00로 미국 공모에서 마감하여 총 모집자금은 약 $4,000,000로 산정되며, 인수인에 의한 할인 및 발행비용 차감 전이다.
주식은 2025년 11월 13일에 Nasdaq Capital Market에서 거래를 시작했다. 인수인은 45일 옵션으로 추가로 최대 150,000주를 공모가로 매입할 수 있으며, 할인과 커미션은 차감된다. 회사는 순수익금을 일반 운전자본, 마케팅 및 판매, 그리고 특정 부채의 상환에 사용할 예정이다. 등록은 양식 S-1(파일 번호 333-289767)으로 2025년 10월 30일에 효력을 발휘하였다. D. Boral Capital LLC가 단독 인수자로 활동했다.
Caring Brands (NASDAQ:CABR) a clôturé une offre publique américaine souscrite de 1 000 000 d'actions à un prix d'offre publique de $4,00 par action pour un produit brut total d'environ $4 000 000, avant les rabais et frais d'émission.
Les actions ont commencé à être négociées sur le Nasdaq Capital Market le 13 novembre 2025. Le souscripteur dispose d'une option de 45 jours pour acheter jusqu'à 150 000 actions supplémentaires au prix d'offre publique, déduction faite des rabais et des commissions. L'entreprise prévoit d'utiliser le produit net pour le fonds de roulement général, le marketing et les ventes, et le remboursement de certaines dettes. L'enregistrement sur le formulaire S-1 (Numéro de fichier 333-289767) a été déclaré efficace le 30 octobre 2025. D. Boral Capital LLC a agi en tant que seul souscripteur.
Caring Brands (NASDAQ:CABR) schloss eine unterzeichnete US-öffentliche Emission von 1.000.000 Aktien zu einem Emissionspreis von $4,00 pro Aktie für Bruttoerlöse von ca. $4.000.000, vor Underwriting-Rabatten und Emissionskosten.
Die Aktien begannen am 13. November 2025 im Nasdaq Capital Market zu handeln. Der Underwriter hat eine 45-tägige Option, bis zu zusätzlich 150.000 Aktien zum Emissionspreis zu erwerben, abzüglich Rabatte und Provisionen. Das Unternehmen beabsichtigt, die Nettogewinne für allgemeines Betriebskapital, Marketing und Vertrieb sowie zur Rückzahlung bestimmter Schulden zu verwenden. Die Registrierung auf Formular S-1 (Datei Nr. 333-289767) wurde am 30. Oktober 2025 wirksam. D. Boral Capital LLC fungierte als alleiniger Underwriter.
Care Brands (NASDAQ:CABR) أُغلِق طرح عام أمريكي مضمّن عبر اكتتاب لفئة 1,000,000 سهم بسعر عرض عام قدره $4.00$4,000,000 قبل خصم المكتتبين وتكاليف العرض.
بدأت الأسهم بالتداول في Nasdaq Capital Market في 13 نوفمبر 2025. للمكتتب خيار مدته 45 يومًا لشراء حتى 150,000 سهماً إضافياً بالسعر المعروض، بعد خصم الخصومات والعمولات. تعتزم الشركة استخدام العوائد الصافية لرأس المال العامل العام والتسويق والمبيعات وسداد بعض الديون. تم إعلان التسجيل في النموذج S-1 (رقم الملف 333-289767) كفعّال في 30 أكتوبر 2025. عملت D. Boral Capital LLC كمكتتب وحيد.
- Raised gross proceeds of $4,000,000
- Listing commenced on Nasdaq (ticker CABR) on Nov 13, 2025
- Underwriter granted 45-day overallotment option for 150,000 shares
- Net proceeds reduced by underwriting discounts and offering expenses
- Potential additional dilution from 150,000-share over-allotment option
- Use of proceeds broadly stated for general working capital and debt repayment
Insights
Caring Brands closed a Nasdaq uplisting and raised
Caring Brands completed an underwritten public offering of 1,000,000 shares at
The business mechanism is straightforward: the company monetized equity through a Nasdaq-listed offering to strengthen liquidity and fund near-term initiatives. Key dependencies include whether the underwriter exercises the 45-day option, how management allocates net proceeds between growth spending and debt repayment, and actual trading liquidity following the uplisting. Watch the 45-day overallotment period and disclosures on net proceeds deployment within the next quarter for concrete impact; these items will clarify dilution and balance-sheet effects within roughly 30–90 days.
FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, today announced the closing of its underwritten U.S. public offering of 1,000,000 shares of common stock at a public offering price of
In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 150,000 shares at the public offering price, less the underwriting discounts and commissions.
Caring Brands intends to use the net proceeds received from this offering for general and working capital purposes, including but not limited to marketing and sales of its proprietary products, and for the repayment of certain debt.
D. Boral Capital LLC (“D. Boral”) acted as the sole underwriter in connection with this offering.
A registration statement on Form S-1 relating to the Offering, as amended, was filed with the Securities and Exchange Commission (the “SEC”) (File Number: 333-289767) and was automatically declared effective on October 30, 2025. The Offering is being made only by means of a prospectus. A copy of the final prospectus was filed with the SEC, which may be obtained, from D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022 by email to info@dboralcapital.com, or by calling (212) 970-5150.
Before you invest, you should read the registration statement, the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the Offering. This press release has been prepared for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor shall there be any offer, solicitation or sale of such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Caring Brands, Inc.
Caring Brands is a wellness consumer products company who offers several over-the-counter (OTC) and cosmetic consumer products. The Company’s product pipeline includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, and a jellyfish sting protective suncare line catering to diverse health and wellness needs. The Company’s method of operation ensures that the mechanism of action of all products is established, efficacy is determined through controlled clinical trials, products are protected by issued and filed patents, and products have acceptable commercial stability.
Forward-Looking Statement
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the proposed Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “believe”, “plan”, “expect”, “intend”, “should”, “seek”, “estimate”, “will”, “aim” and “anticipate” or other similar expressions in the prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.
For further information, please contact:
Brian S John
investors@caringbrands.com
(561) 896-7616